14,947 research outputs found

    Spin Freezing in the Spin Liquid Compound FeAl2O4

    Full text link
    Spin freezing in the AA-site spinel FeAl2_2O4_4 which is a spin liquid candidate is studied using remnant magnetization and nonlinear magnetic susceptibility and isofield cooling and heating protocols. The remnant magnetization behavior of FeAl2_2O4_4 differs significantly from that of a canonical spin glass which is also supported by analysis of the nonlinear magnetic susceptibility term χ3(T)\chi_3 (T). Through the power-law analysis of χ3(T)\chi_3 (T), a spin-freezing temperature, TgT_g = 11.4±\pm0.9~K and critical exponent, γ\gamma = 1.48±\pm0.59 are obtained. Cole-Cole analysis of magnetic susceptibility shows the presence of broad spin relaxation times in FeAl2_2O4_4, however, the irreversible dc susceptibility plot discourages an interpretation based on conventional spin glass features. The magnetization measured using the cooling-and-heating-in-unequal-fields protocol brings more insight to the magnetic nature of this frustrated magnet and reveals unconventional glassy behaviour. Combining our results, we arrive at the conclusion that the present sample of FeAl2_2O4_4 consists of a majority spin liquid phase with "glassy" regions embedded.Comment: 5 pages, 6 figs, 2-column, Accepted to Phys. Rev.

    Double-phase transition and giant positive magnetoresistance in the quasi-skutterudite Gd3_3Ir4_4Sn13_{13}

    Full text link
    The magnetic, thermodynamic and electrical/thermal transport properties of the caged-structure quasi-skutterudite Gd3_3Ir4_4Sn13_{13} are re-investigated. The magnetization M(T)M(T), specific heat Cp(T)C_p(T) and the resistivity ρ(T)\rho(T) reveal a double-phase transition -- at TN1T_{N1}\sim 10~K and at TN2T_{N2}\sim 8.8~K -- which was not observed in the previous report on this compound. The antiferromagnetic transition is also visible in the thermal transport data, thereby suggesting a close connection between the electronic and lattice degrees of freedom in this Sn-based quasi-skutterudite. The temperature dependence of ρ(T)\rho(T) is analyzed in terms of a power-law for resistivity pertinent to Fermi liquid picture. Giant, positive magnetoresistance (MR) \approx 80%\% is observed in Gd3_3Ir4_4Sn13_{13} at 2~K with the application of 9~T. The giant MR and the double magnetic transition can be attributed to the quasi-cages and layered antiferromagnetic structure of Gd3_3Ir4_4Sn13_{13} vulnerable to structural distortions and/or dipolar or spin-reorientation effects. The giant value of MR observed in this class of 3:4:13 type alloys, especially in a Gd-compound, is the highlight of this work.Comment: 20 pages single column, 7 figures, 1 table; Accepted to J. Appl. Phys., 201

    Cost variation analysis of antihypertensive drugs acting through renin angiotensin aldosterone axis modulation

    Get PDF
    Background: Several brands of antihypertensive drugs are available in the Indian market with huge price variations. This study was undertaken to find out the percentage cost variation and cost ratio of antihypertensive drugs acting through renin angiotensin aldosterone axis modulation.Methods: Costs of different brands of renin angiotensin aldosterone axis modulatory drugs with antihypertensive action for the same dosage form and strength were found out using current index of medical specialties-134, July-October 2016. The maximum and minimum price of different brands of each drug was noted. Data was entered in Microsoft excel 2010. Percentage cost variation and cost ratio was calculated for each drug.Results: 16 antihypertensive drugs were analysed. Most of them were tablets. Ramipril and Valsartan were available as capsules also. Among tablets, percentage cost variation was highest for Atenolol 12.5 mg (683.93%) and least for Bisoprolol 2.5 mg (3.6538%). Valsartan capsules (160 mg) had no difference in the costs between the available 2 brands. Cost ratio ranged from 1.04 to 7.84 among the tablet form of drugs.Conclusions: There is a huge difference in the cost of antihypertensive drugs manufactured by different companies in the same strength and dosage form. To promote rational drug use and cost effective therapy, it is essential to create an awareness among clinicians regarding the availability of multiple brands for these drugs and the discrepancies in their costs
    corecore